51
Views
21
CrossRef citations to date
0
Altmetric
Original Research

GX1-conjugated poly(lactic acid) nanoparticles encapsulating Endostar for improved in vivo anticolorectal cancer treatment

, , , , , , , & show all
Pages 3791-3802 | Published online: 28 May 2015

References

  • MotzerRJNosovDEisenTTivozanib versus sorafenib as initial targeted therapy for patients with advanced renal cell carcinoma: results from a phase III randomized, open-label, multicenter trialJ Clin Oncol20123015277S
  • Brannon-PeppasLBlanchetteJONanoparticle and targeted systems for cancer therapyAdv Drug Deliv Rev201264206212
  • ZhangZLeeJCLinLActivation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancerNat Genet201244885286022751098
  • WeisSMChereshDATumor angiogenesis: molecular pathways and therapeutic targetsNat Med201117111359137022064426
  • WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med19913241181701519
  • BreitbachCJArulanandamRDe SilvaNOncolytic vaccinia virus disrupts tumor-associated vasculature in humansCancer Res20137341265127523393196
  • ChoueiriTKXieWKollmannsbergerCThe impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapyJ Urol20111851606621074201
  • CurnisFSacchiALonghiRColomboBGasparriACortiAIsoDGR-tagged albumin: A new αvβ3 selective carrier for nanodrug delivery to tumorsSmall20129567367823143930
  • HongHYangKZhangYIn vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographeneACS Nano2012632361237022339280
  • SchmiederAHWinterPMWilliamsTAMolecular MR imaging of neovascular progression in the V×2 tumor with αvβ3-targeted paramagnetic nanoparticlesRadiology2013268247048023771914
  • SugaharaKNTeesaluTKarmaliPPCoadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugsScience201032859811031103520378772
  • ChenKSunXNiuGEvaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculatureMol Imaging Biol20121419610521360213
  • KenterGGWeltersMJValentijnARPhase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicityClin Cancer Res200814116917718172268
  • ChenBCaoSZhangYA novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapyBMC Cell Biol2009101637319740430
  • WuKNieYGuoCChenYDingJFanDMolecular basis of therapeutic approaches to gastric cancerJ Gastroenterol Hepatol2009241374119196394
  • ChenKYa pLPParkRA Cy5. 5-labeled phage-displayed peptide probe for near-infrared fluorescence imaging of tumor vasculature in living miceAmino Acids20124241329133721212998
  • LingYYangYLuNEndostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cellsBiochem Biophys Res Commun20073611798417644065
  • XuHXHuangXEQianZYXuXLiYLiCGClinical observation of Endostar® combined with chemotherapy in advanced colorectal cancer patientsAsian Pac J Cancer Prev201112113087309022393994
  • ChenWHuSSuitable carriers for encapsulation and distribution of Endostar: comparison of Endostar-loaded particulate carriersInt J Nanomedicine2011201161535154121845043
  • ChenXGambhirSSCheonJTheranostic nanomedicineAcc Chem Res201144101029103821545096
  • McCarthyJRThe future of theranostic nanoagentsNanomedicine20094769369519839803
  • JamesMLGambhirSSA molecular imaging primer: modalities, imaging agents, and applicationsPhysiol Rev201292289796522535898
  • WeisslederRMolecular imaging in cancerScience200631257771168117116728630
  • WeisslederRPittetMJImaging in the era of molecular oncologyNature2008452718758058918385732
  • LiuZLiuSNiuGWangFLiuSChenXOptical imaging of integrin αv β3 expression with near-infrared fluorescent RGD dimer with tetra (ethylene glycol) linkersMol Imaging201091212920128995
  • KaufmannBACarrCLBelcikJTMolecular imaging of the initial inflammatory response in atherosclerosis implications for early detection of diseaseArterioscler Thromb Vasc Biol2010301545919834105
  • TroyanSLFrangioniJVThe FLARE™ intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mappingAnn Surg Oncol200916102943295219582506
  • JangBParkJYTungCHKimIHChoiYGold nanorod–photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivoACS Nano2011521086109421244012
  • HilderbrandSAWeisslederRNear-infrared fluorescence: application to in vivo molecular imagingCurr Opin Chem Biol2010141717919879798
  • Sevick-MuracaETranslation of near-infrared fluorescence imaging technologies: emerging clinical applicationsAnnu Rev Med20126321723122034868
  • PrabhakarUMaedaHJainRKChallenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncologyCancer Res20137382412241723423979
  • BalaVRaoSBoydBJPrestidgeCAProdrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38J Control Release20131721486123928356
  • ParkJHChoHJYoonHYHyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug deliveryJ Control Release20141749810824280260
  • LingYLuNGaoYEndostar induces apoptotic effects in HUVECs through activation of caspase-3 and decrease of Bcl-2Anticancer Res200929141141719331180
  • XuXMaoWChenQEndostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathwayPLoS One201499e10746325232946
  • ChenBCaoSZhangYA novel peptide (GX1) homing to gastric cancer vasculature inhibits angiogenesis and cooperates with TNF alpha in anti-tumor therapyBMC Cell Biol200910637319740430
  • BergersGBenjaminLETumorigenesis and the angiogenic switchNat Rev Cancer20033640141012778130
  • FolkmanJAngiogenesis in cancer, vascular, rheumatoid and other diseaseNat Med19951127317584949
  • CaoSLiuYLiXExpression, purification, and characterization of recombinant protein GX1-rmhTNFalphaMol Biotechnol20094311719357993
  • HuHYinJWangMGX1 targeting delivery of rmhTNFalpha evaluated using multimodality imagingInt J Pharm2013461118119124269209
  • HuiXHanYLiangSSpecific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSCJ Control Release20081312869318700158
  • HsuARHouLCVeeravaguAIn vivo near-infrared fluorescence imaging of integrin αvβ3 in an orthotopic glioblastoma modelMol Imaging Biol20068631532317053862
  • HuYLJahangiriADelayMAghiMKTumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapyCancer Res201272174294429922915758
  • StollBRMiglioriniCKadambiAMunnLLJainRKA mathematical model of the contribution of endothelial progenitor cells to angiogenesis in tumors: implications for antiangiogenic therapyBlood200310272555256112775571
  • LiXQShangBYWangDCZhangSHWuSYZhenYSEndostar, a modified recombinant human endostatin, exhibits synergistic effects with dexamethasone on angiogenesis and hepatoma growthCancer Lett2011301221222021216091
  • FuXHLiJZouYEndostar enhances the antineoplastic effects of combretastatin A4 phosphate in an osteosarcoma xenograftCancer Lett2011312110911621893381